Suchergebnisse - "Fibrinolytic Agents"

PubPharm (184)

1

Toward Individual Treatment in Cervical Artery Dissection : Subgroup Analysis of the TREAT-CAD Randomized Trial

enthalten in: Annals of neurology | 2024

von Kaufmann, J. | Gensicke, H. | Schaedelin, S. | +33

2

Rationale and design of the optimal antithrombotic treatment for acute coronary syndrome patients with concomitant atrial fibrillation and implanted with new-generation drug-eluting stent : OPtimal management of anTIthroMbotic Agents (OPTIMA)-4 trial

enthalten in: Clinical cardiology | 2023

von Gong, X. | Hua, R. | Bai, J. | +16

3

Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke : The ARAMIS Randomized Clinical Trial

enthalten in: JAMA | 2023

von Chen, H. | Cui, Y. | Zhou, Z. | +41

CommentIn: Ann Intern Med. 2023 Oct;176(10):JC110. - PMID 37782921

4

Effects of ticagrelor monotherapy vs. clopidogrel monotherapy on platelet reactivity : a randomized, crossover clinical study (SINGLE study)

enthalten in: Platelets | 2022

von He, M. | Yan, W. | Zhang, Y. | +7

5

The EvidenceNOW Practice Support Initiative : The Heart of Virginia Healthcare

enthalten in: Journal of the American Board of Family Medicine : JABFM | 2022

von Kuzel, A. | Cuellar, A. | Nichols, L.

6

Rationale and design of the AXIOMATIC-SSP phase II trial : Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention

enthalten in: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association | 2022

von Sharma, M. | Molina, C. | Toyoda, K. | +16

7

Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke : A Post Hoc Analysis From the AUGUSTUS Trial

enthalten in: JAMA cardiology | 2022

von Bahit, M. | Vora, A. | Li, Z. | +15

8

Rationale and design of the safe and timely antithrombotic removal - ticagrelor (STAR-T) trial : A prospective, multi-center, double-blind, randomized controlled trial evaluating reductions in postoperative bleeding with intraoperative removal of ticagrelor by the drugsorb™-ATR device in patients undergoing cardiothoracic surgery within 48 hours from last ticagrelor dose

enthalten in: American heart journal | 2022

von Gibson, C. | Mack, M. | Lee, V. | +8

9

Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on-treatment platelet reactivity : the OPTImal Management of Antithrombotic Agents (OPTIMA)-2 Trial

enthalten in: British journal of haematology | 2022

von Ying, L. | Wang, J. | Li, J. | +18

CommentIn: Br J Haematol. 2022 Jan;196(2):272-273. - PMID 34734417

10

A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes : role of dosing and glycaemic control

enthalten in: Cardiovascular diabetology | 2021

von Parker, W. | Sagar, R. | Kurdee, Z. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]